Jupiter Life Line Hospitals Limited (BOM:543980)
1,489.25
+13.75 (0.93%)
At close: Feb 20, 2025
BOM:543980 Statistics
Total Valuation
BOM:543980 has a market cap or net worth of INR 97.72 billion. The enterprise value is 94.43 billion.
Market Cap | 97.72B |
Enterprise Value | 94.43B |
Important Dates
The last earnings date was Friday, February 7, 2025.
Earnings Date | Feb 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +5.78% |
Shares Change (QoQ) | +0.04% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 19.29M |
Valuation Ratios
The trailing PE ratio is 50.40.
PE Ratio | 50.40 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 7.78 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 48.70 |
EV / Sales | 7.73 |
EV / EBITDA | 34.19 |
EV / EBIT | 40.83 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | 102.39 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 12.18% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.47% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +3.47% |
50-Day Moving Average | 1,551.68 |
200-Day Moving Average | 1,394.57 |
Relative Strength Index (RSI) | 42.39 |
Average Volume (20 Days) | 1,618 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:543980 had revenue of INR 12.22 billion and earned 1.94 billion in profits. Earnings per share was 29.25.
Revenue | 12.22B |
Gross Profit | 7.65B |
Operating Income | 2.28B |
Pretax Income | 2.58B |
Net Income | 1.94B |
EBITDA | 2.73B |
EBIT | 2.28B |
Earnings Per Share (EPS) | 29.25 |
Balance Sheet
Cash & Cash Equivalents | 3.29B |
Total Debt | n/a |
Net Cash | 3.29B |
Net Cash Per Share | n/a |
Equity (Book Value) | 12.58B |
Book Value Per Share | 192.03 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 62.62%, with operating and profit margins of 18.67% and 15.87%.
Gross Margin | 62.62% |
Operating Margin | 18.67% |
Pretax Margin | 21.10% |
Profit Margin | 15.87% |
EBITDA Margin | 22.34% |
EBIT Margin | 18.67% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.07%.
Dividend Per Share | 1.00 |
Dividend Yield | 0.07% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | n/a |
Buyback Yield | -5.78% |
Shareholder Yield | -5.71% |
Earnings Yield | 1.98% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |